Merck & Co.

Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus

Novo Nordisk will now start pricing negotiations in Japan ahead of a future launch, which will be carried out by the company in collaboration with Merck &Co/MSD, its co-promotion ... 2 diabetics than Merck &Co’s oral DPP-4 inhibitor Januvia (sitagliptin

New Japanese approvals include first OK for GSK’s anaemia drug Duvroq

GSK co-developed Duvroq (daprodustat) with Kyowa Kirin, which has a long heritage in the CKD anaemia market with its injectable erythropoiesis-stimulating agent (ESA) Espo (epoetin alfa) and will be ... Novartis’ drug was beaten to the Japanese market

Encouraging patient participation in real-world studies

A variety of methodologies – ranging from interviews, surveys, social listening and co-design workshops to study visit simulations – can be used to gain a holistic view of patients’ ecosystem and how

Facing up to virtual reality

All the key stakeholder groups must work together to co-create innovations that transform the congress experience, and deliver educational content in ways that engage and inspire.

Strategic planning: why do good strategies sometimes fail?

This people-centric process of co-creation promotes a sense of commitment and support that’s essential for effective execution.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]